Pediatric rheumatology

Effect of Characteristic Inflammatory and Structural Pelvic Magnetic Resonance Imaging Lesions on Expert Assessment of Axial Juvenile Spondyloarthritis

J RheumatolPublished Cross-sectional study

Authors' conclusion

The addition of imaging data affected directionality and improved high confidence agreement of expert assessment of axial disease.

Study context

Population
Patients with juvenile spondyloarthritis (JSpA) with suspected axial disease3 experts per case
Participants
303 patients
Exposure
Expert assessment with clinical data alone vs with clinical and magnetic resonance imaging (MRI) data
Outcome
Expert agreement (≥ 2/3 experts rating ≤ −1 or ≥ 1) on presence of axial disease
Methodological detailsmodified Poisson regression models
  • Modified Poisson regression models

Main finding

As reported in the abstract

Expert agreement on axial disease

Clinical data

89.8%

272 events

Adding imaging data affected agreement
38.9% (118/303)
Adding imaging data affected directionality of agreement
23.4% (71/303)
Agreement facilitated
26/31
Agreement lost
21/272
Directionality changed from axial disease absent to present
33
Directionality changed from present to absent
38

Observational data: associations, not effects.

Further findings

Factors independently associated with expert agreement (final model area under the receiver-operating characteristic (AUROC) 0.93)

RR (95% CI)
HLA-B271.41 (1.14–1.74)
Pain improvement with activity1.27 (1.05–1.54)
Bone marrow edema on MRI4.08 (2.91–5.73)
Factors independently associated with expert agreement (final model AUROC 0.93) — Final model AUROC
0.93

Original publication

Effect of Characteristic Inflammatory and Structural Pelvic Magnetic Resonance Imaging Lesions on Expert Assessment of Axial Juvenile Spondyloarthritis. J Rheumatol. Published 15 January 2025. doi:10.3899/jrheum.2024-0696

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.